PATENT CLAIM ANALYSIS

Application Number: 15950367
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "489000"]

Abstract:
The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm.

Claim (Index 27):
A method of administering meloxicam to a human in need thereof comprising intravenously or intramuscularly injecting the nanoparticulate pharmaceutical dosage form of  claim 24  into the human.

Metadata:
- Claim Count in Document: 11.0
- Percentile: 91.0
- Lexical Diversity: 1.0
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15437534', '10784900', '15130396', '14133191', '15130255']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6771665597757524
- 35 USC 102 Novelty (BERT): 0.5344952588423612
- Combined Prediction Score: 0.6628994296824132
- Mean Citation Score: 260.24395400000003
- Max Citation Score: 344.96005
- Similarity Product: 228.4229340714365

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test